Chronic Low Back Pain (CLBP)
0
Pipeline Programs
4
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Innovation PharmaceuticalsMA - Wakefield
1 programMixed realities rehabilitation programN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2024
2025
2026
2027
Innovation PharmaceuticalsMixed realities rehabilitation program
AbbottMuscleSCS
BiocorpRemote rehabilitation
Clinical Trials (3)
Total enrollment: 430 patients across 3 trials
RE-SCALE: Rehabilitation Engagement and Scaled Access With eXtended Reality and Artificial Intelligence
Start: Jan 2027Est. completion: Dec 2027314 patients
N/ANot Yet Recruiting
A Prospective Evaluation of Spinal Cord Induced Muscle Stimulation (MuscleSCS) for the Treatment of Chronic Low Back Pain
Start: Oct 2025Est. completion: Jan 202730 patients
N/ARecruiting
Chronic Low Back Pain: TOTALSPINE - UO04
Start: Aug 2024Est. completion: Aug 202686 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 430 patients
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.